Elsevier

European Urology Oncology

Volume 5, Issue 5, October 2022, Pages 601-602
European Urology Oncology

Letter to the Editor
Re: Stefano Fanti, Alberto Briganti, Louise Emmett, et al. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy. Eur Urol Oncol. 2022;5:530–6: Extended Use of PSMA PET/CT in Candidates for Focal Therapy

https://doi.org/10.1016/j.euo.2022.06.006Get rights and content

Cited by (0)

View full text